NDC 71285-0003-1
This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.
- Requested NDC
- 71285-0003-1
- Product root
- 71285-0003
- Identity scope
- Package
- Primary current NDC product row
- Not present
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| compounder | package | 71285-0003 | 71285-0003-1 | COMPOUNDER | Outsourcing facility compounded drug report | 2020-1 | 2026-10-13 |
| compounder | package | 71285-0003 | 71285-0003-1 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-2 | 2026-10-13 |
| compounder | package | 71285-0003 | 71285-0003-1 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-1 | 2026-10-13 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-27 00:00 UTC · source 2025-08-20 | compounder | package | 71285-0003 | 71285-0003-1 | COMPOUNDER | Outsourcing facility compounded drug report | 2020-1 | compounder / compounders_ndc_directory.zip | af8e9b524e63… | ca326a94a5e9… |
| 2025-08-27 00:00 UTC · source 2025-08-20 | compounder | package | 71285-0003 | 71285-0003-1 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-2 | compounder / compounders_ndc_directory.zip | af8e9b524e63… | ca326a94a5e9… |
| 2025-08-27 00:00 UTC · source 2025-08-20 | compounder | package | 71285-0003 | 71285-0003-1 | COMPOUNDER | Outsourcing facility compounded drug report | 2019-1 | compounder / compounders_ndc_directory.zip | af8e9b524e63… | ca326a94a5e9… |
Compounder NDC reports#
| Establishment | FEI | Product NDC | Package NDC | Product | Active ingredients | Reporting period | Normalization |
|---|---|---|---|---|---|---|---|
| "Central Admixture Pharmacy Services, Inc.(019684530)" | 71285-0003 | 71285-0003-1 | "dextrose Monohydrate; Potassium Chloride; Aspartic Acid; Trisodium Citrate Dihydrate; Sodium Phosphate, Monobasic, Monohydrate; Anhydrous Dextrose; Citric Acid Monohydrate; Tromethamine; Glutamic Acid" | 25.27 g/1000 mL; 80 meq/1000 mL; 9.8 g/1000 mL; 59.175 g/1000 mL; 4.995 g/1000 mL; 104.4 g/1000 mL; 7.3575 g/1000 mL; 8.1 g/1000 mL; 10.7 g/1000 mL | 2020-1 | valid | |
| "Central Admixture Pharmacy Services, Inc.(019684530)" | 71285-0003 | 71285-0003-1 | "dextrose Monohydrate; Potassium Chloride; Aspartic Acid; Trisodium Citrate Dihydrate; Sodium Phosphate, Monobasic, Monohydrate; Anhydrous Dextrose; Citric Acid Monohydrate; Tromethamine; Glutamic Acid" | 25.27 g/1000 mL; 80 meq/1000 mL; 9.8 g/1000 mL; 59.175 g/1000 mL; 4.995 g/1000 mL; 104.4 g/1000 mL; 7.3575 g/1000 mL; 8.1 g/1000 mL; 10.7 g/1000 mL | 2019-2 | valid | |
| "Central Admixture Pharmacy Services, Inc.(019684530)" | 71285-0003 | 71285-0003-1 | "dextrose Monohydrate; Potassium Chloride; Aspartic Acid; Trisodium Citrate Dihydrate; Sodium Phosphate, Monobasic, Monohydrate; Anhydrous Dextrose; Citric Acid Monohydrate; Tromethamine; Glutamic Acid" | 25.27 g/1000 mL; 80 meq/1000 mL; 9.8 g/1000 mL; 59.175 g/1000 mL; 4.995 g/1000 mL; 104.4 g/1000 mL; 7.3575 g/1000 mL; 8.1 g/1000 mL; 10.7 g/1000 mL | 2019-1 | valid |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.